Skip to content

Clinical trials

Phase 2 Fibrosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Phase 2 Country / region: France Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20061
20091
20101
20123
20133
20141
20151
20161
20171
20191
20211
20221
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated6
Active, not recruiting2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
Assistance Publique - Hôpitaux de Paris3
Genfit3
Association pour la Recherche sur les Maladies Hépatiques Virales1
Axcella Health, Inc1
Debiopharm International SA1
French National Agency for Research on AIDS and Viral Hepatitis1
Galmed Research and Development, Ltd.1
Gustave Roussy, Cancer Campus, Grand Paris1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis24
Non-alcoholic Fatty Liver Disease6
Liver Diseases5
Fatty Liver4
Acute-On-Chronic Liver Failure2
Diabetes Mellitus2
Hepatic Encephalopathy2
Hepatitis C2
Hypertension, Portal2
Idiopathic Pulmonary Fibrosis2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.